down arrow

OPC Pharmaceutical JSC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000OPC9
VND
22,600.00
100 (0.44%)

Dec 12

STC

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

21,000.0025,400.00
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

The company has declared Negative results for the last 9 consecutive quarters

  • INTEREST(9M) At VND 1,758.46 MM has Grown at 100.03%
  • OPERATING CASH FLOW(Y) Lowest at VND 64,003.17 MM
  • ROCE(HY) Lowest at 11.03%
2

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND 1,441,145 Million (Small Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.30

stock-summary
Return on Equity

11.14%

stock-summary
Price to Book

1.64

Revenue and Profits:
Net Sales:
236,994 Million
(Quarterly Results - Jun 2025)
Net Profit:
18,669 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.31%
0%
-1.31%
6 Months
-3.62%
0%
-3.62%
1 Year
-2.38%
0%
-2.38%
2 Years
-1.74%
0%
-1.74%
3 Years
-3.83%
0%
-3.83%
4 Years
-4.45%
0%
-4.45%
5 Years
-7.68%
0%
-7.68%

OPC Pharmaceutical JSC for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
3.13%
EBIT Growth (5y)
-0.03%
EBIT to Interest (avg)
53.82
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
1.28
Tax Ratio
19.56%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
28.43%
ROE (avg)
15.33%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.69
EV to EBIT
9.71
EV to EBITDA
8.21
EV to Capital Employed
2.02
EV to Sales
1.19
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
20.79%
ROE (Latest)
10.56%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 12.60% vs -37.64% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -8.99% vs -33.99% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "236,993.70",
          "val2": "210,466.40",
          "chgp": "12.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29,932.00",
          "val2": "34,791.40",
          "chgp": "-13.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "18,669.00",
          "val2": "20,512.70",
          "chgp": "-8.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "103.60%",
          "val2": "139.70%",
          "chgp": "-3.61%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -3.61% vs -14.23% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -10.86% vs -18.37% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "968,576.00",
          "val2": "1,004,887.00",
          "chgp": "-3.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "156,734.90",
          "val2": "169,015.10",
          "chgp": "-7.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "6,700.50",
          "val2": "334.50",
          "chgp": "1,903.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "93,395.00",
          "val2": "104,775.40",
          "chgp": "-10.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "138.80%",
          "val2": "145.40%",
          "chgp": "-0.66%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
236,993.70
210,466.40
12.60%
Operating Profit (PBDIT) excl Other Income
29,932.00
34,791.40
-13.97%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
18,669.00
20,512.70
-8.99%
Operating Profit Margin (Excl OI)
103.60%
139.70%
-3.61%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 12.60% vs -37.64% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -8.99% vs -33.99% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
968,576.00
1,004,887.00
-3.61%
Operating Profit (PBDIT) excl Other Income
156,734.90
169,015.10
-7.27%
Interest
6,700.50
334.50
1,903.14%
Exceptional Items
0.00
0.00
Consolidate Net Profit
93,395.00
104,775.40
-10.86%
Operating Profit Margin (Excl OI)
138.80%
145.40%
-0.66%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -3.61% vs -14.23% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -10.86% vs -18.37% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About OPC Pharmaceutical JSC stock-summary
stock-summary
OPC Pharmaceutical JSC
Pharmaceuticals & Biotechnology
OPC Pharmaceutical Joint-Stock Company (OPC) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets drugs and other medical products from natural pharmaceutical materials which are cultivated and processed at the facilities of the Company. It is also involved in the production and wholesale trading of pharmaceutical chemicals and supplies, as well as functional food. Moreover, the Company is involved in wine distillery and bottled water manufacturing. On June 13, 2014, the Company announced that it has dissolved its joint venture named OPC EXIM Real Estate Joint Stock Company.
Company Coordinates stock-summary
Company Details
1017 Hong Bang, Phuong 12, Quan 6 , HO CHI MINH None : None
stock-summary
Tel: 84 8 3751711184 8 37517111
stock-summary
https://opcpharma.com
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."